A citation-based method for searching scientific literature


List of co-cited articles
83 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
33

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
33


Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
K Han, S Nofech-Mozes, S Narod, W Hanna, D Vesprini, R Saskin, C Taylor, I Kong, L Paszat, E Rakovitch. Clin Oncol (R Coll Radiol) 2012
34
25

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
111
25

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
25

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri Davies, Philip S Bernard, Joel S Parker,[...]. J Natl Cancer Inst 2009
25

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
38
25

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
320
25

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
443
25

Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
423
25

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
224
25

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
187
25

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
184
25

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
194
25



Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Nadia P Castro, Cynthia A B T Osório, César Torres, Elen P Bastos, Mário Mourão-Neto, Fernando A Soares, Helena P Brentani, Dirce M Carraro. Breast Cancer Res 2008
94
16

bcl-2 expression in the spectrum of preinvasive breast lesions.
K P Siziopikou, J E Prioleau, J R Harris, S J Schnitt. Cancer 1996
66
16

Regulation of in situ to invasive breast carcinoma transition.
Min Hu, Jun Yao, Danielle K Carroll, Stanislawa Weremowicz, Haiyan Chen, Daniel Carrasco, Andrea Richardson, Shelia Violette, Tatiana Nikolskaya, Yuri Nikolsky,[...]. Cancer Cell 2008
360
16

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.
Peter T Simpson, Theo Gale, Jorge S Reis-Filho, Chris Jones, Suzanne Parry, John P Sloane, Andrew Hanby, Sarah E Pinder, Andrew H S Lee, Steve Humphreys,[...]. Am J Surg Pathol 2005
191
16

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
370
16

On the origin and progression of ductal carcinoma in the human breast.
S R Wellings, H M Jensen. J Natl Cancer Inst 1973
262
16

Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
620
16

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
Annette Lebeau, Angela Unholzer, Gudrun Amann, Michaela Kronawitter, Ingo Bauerfeind, Andrea Sendelhofert, Anette Iff, Udo Löhrs. Breast Cancer Res Treat 2003
64
16

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
89
16

Ductal carcinoma in situ: state of the science and roadmap to advance the field.
Henry M Kuerer, Constance T Albarracin, Wei T Yang, Robert D Cardiff, Abenaa M Brewster, W Fraser Symmans, Nola M Hylton, Lavinia P Middleton, Savitri Krishnamurthy, George H Perkins,[...]. J Clin Oncol 2009
95
16

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Sevilay Altintas, Kathleen Lambein, Manon T Huizing, Geert Braems, Fernando Tjin Asjoe, Hilde Hellemans, Eric Van Marck, Joost Weyler, Marleen Praet, Rudy Van den Broecke,[...]. Breast J 2009
33
16


Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
245
16

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
16


Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
201
16

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
193
16


Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D C Allred, J M Harvey, M Berardo, G M Clark. Mod Pathol 1998
16

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.
D H Morrison, D Rahardja, E King, Y Peng, V R Sarode. Br J Cancer 2012
66
16


Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
217
16

Prognostic and predictive values of the immunoscore in patients with rectal cancer.
Maria-Gabriela Anitei, Guy Zeitoun, Bernhard Mlecnik, Florence Marliot, Nacilla Haicheur, Ana-Maria Todosi, Amos Kirilovsky, Christine Lagorce, Gabriela Bindea, Dan Ferariu,[...]. Clin Cancer Res 2014
222
16

Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
James Helm, Barbara A Centeno, Domenico Coppola, Marcovalerio Melis, Mark Lloyd, Jong Y Park, Dung-Tsa Chen, Mokenge P Malafa. Cancer 2009
36
16

Observer variability in histopathological reporting of cervical biopsy specimens.
A J Robertson, J M Anderson, J S Beck, R A Burnett, S R Howatson, F D Lee, A M Lessells, K M McLaren, S M Moss, J G Simpson. J Clin Pathol 1989
274
16

Vascular measurements correlate with estrogen receptor status.
Mark C Lloyd, Khalid O Alfarouk, Daniel Verduzco, Marilyn M Bui, Robert J Gillies, Muntaser E Ibrahim, Joel S Brown, Robert A Gatenby. BMC Cancer 2014
33
16

Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
Marcial García Rojo, Gloria Bueno, Janina Slodkowska. Folia Histochem Cytobiol 2009
86
16

Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence.
Dana Faratian, Jason Christiansen, Mark Gustavson, Christine Jones, Christopher Scott, InHwa Um, David J Harrison. J Vis Exp 2011
21
16

AI (artificial intelligence) in histopathology--from image analysis to automated diagnosis.
Klaus Kayser, Jürgen Görtler, Milica Bogovac, Aleksandar Bogovac, Torsten Goldmann, Ekkehard Vollmer, Gian Kayser. Folia Histochem Cytobiol 2009
32
16

A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps.
Katharina Glatz, Bobbi Pritt, Dieter Glatz, Arndt Hartmann, Michael J O'Brien, Hagen Blaszyk. Am J Clin Pathol 2007
77
16

Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it?
Mark C Lloyd, Pushpa Allam-Nandyala, Chetna N Purohit, Nancy Burke, Domenico Coppola, Marilyn M Bui. J Pathol Inform 2010
57
16

Observer variability in the histologic assessment of oral premalignant lesions.
A Karabulut, J Reibel, M H Therkildsen, F Praetorius, H W Nielsen, E Dabelsteen. J Oral Pathol Med 1995
178
16

Ductal carcinoma in situ: a proposal for a new classification.
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994
436
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.